1. Home
  2. MSDL vs INDV Comparison

MSDL vs INDV Comparison

Compare MSDL & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSDL
  • INDV
  • Stock Information
  • Founded
  • MSDL 2019
  • INDV 1994
  • Country
  • MSDL United States
  • INDV United States
  • Employees
  • MSDL N/A
  • INDV N/A
  • Industry
  • MSDL
  • INDV Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSDL
  • INDV Health Care
  • Exchange
  • MSDL NYSE
  • INDV Nasdaq
  • Market Cap
  • MSDL 1.7B
  • INDV 1.4B
  • IPO Year
  • MSDL N/A
  • INDV N/A
  • Fundamental
  • Price
  • MSDL $19.29
  • INDV $13.52
  • Analyst Decision
  • MSDL Hold
  • INDV Strong Buy
  • Analyst Count
  • MSDL 5
  • INDV 2
  • Target Price
  • MSDL $20.00
  • INDV $14.50
  • AVG Volume (30 Days)
  • MSDL 408.8K
  • INDV 1.1M
  • Earning Date
  • MSDL 01-01-0001
  • INDV 07-24-2025
  • Dividend Yield
  • MSDL 11.41%
  • INDV N/A
  • EPS Growth
  • MSDL N/A
  • INDV N/A
  • EPS
  • MSDL N/A
  • INDV N/A
  • Revenue
  • MSDL N/A
  • INDV $1,170,000,000.00
  • Revenue This Year
  • MSDL $1,597.39
  • INDV N/A
  • Revenue Next Year
  • MSDL $15.10
  • INDV $3.00
  • P/E Ratio
  • MSDL N/A
  • INDV N/A
  • Revenue Growth
  • MSDL N/A
  • INDV 4.09
  • 52 Week Low
  • MSDL $17.59
  • INDV $7.33
  • 52 Week High
  • MSDL $23.83
  • INDV $16.50
  • Technical
  • Relative Strength Index (RSI)
  • MSDL 47.53
  • INDV 59.79
  • Support Level
  • MSDL $18.85
  • INDV $13.45
  • Resistance Level
  • MSDL $19.35
  • INDV $14.47
  • Average True Range (ATR)
  • MSDL 0.27
  • INDV 0.46
  • MACD
  • MSDL -0.03
  • INDV -0.10
  • Stochastic Oscillator
  • MSDL 50.28
  • INDV 25.71

About MSDL MORGAN STANLEY DIRECT LENDING FUND

Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.

About INDV Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Share on Social Networks: